Article Details

bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene ... - Yahoo Finance

Retrieved on: 2024-12-08 17:37:20

Tags for this article:

Click the tags to see associated articles and topics

bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene ... - Yahoo Finance. View article details on hiswai:

Excerpt

... gene therapy for sickle cell disease." said Richard Colvin, M.D., Ph.D., chief medical officer, bluebird bio. "These data continue to distinguish ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up